Abstract OT1-04-01: Cambridge brain mets trial 1 (CamBMT1): A proof-of-principle phase 1b / randomised phase 2 study of afatinib penetration into brain metastases for patients undergoing neurosurgical resection, both with and without prior low-dose, targeted radiotherapy
Baird, R Ramenatte, N Watts, C Jonson, A Jones, L Biggs, H Harrison, E Oberg, I Bullen, G Williams, M
Baird, R
Ramenatte, N
Watts, C
Jonson, A
Jones, L
Biggs, H
Harrison, E
Oberg, I
Bullen, G
Williams, M
Citations
Altmetric:
Abstract
Description
Date
2017-02-14
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Abstract OT1-04-01: Cambridge brain mets trial 1 (CamBMT1): A proof-of-principle phase 1b / randomised phase 2 study of afatinib penetration into brain metastases for patients undergoing neurosurgical resection, both with and without prior low-dose, targeted radiotherapy 2017, 77 (4 Supplement):OT1-04-01 Cancer Research